Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval

Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval

Submitted by admin on January 17, 2024 - 9:30am
Source: 
Clinical Trials Arena
News Tags: 
CRISPR
gene editing
clinical trials
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
EdiGene
Shanghai Vitalgen BioPharma
Regeneron
Vor Biopharma
Headline: 
Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval
snippet: 

There are several CRISPR therapies in Phase II and III trials which could be landmark approvals for their respective fields.

Do Not Allow Advertisers to Use My Personal information